← SynDRA
GW-405833
SynDRA canonical compound SYN0087156 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CNR2 |
|---|
| Mechanism of action | Cannabinoid receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Cannabinoid receptor agonist
- CNR2 PARTIAL AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- APP
- TP53
- TDP1
- SMAD3
- PTH1R
- POLI
- NFE2L2
- MAPT
- MAPK1
- IDH1
- HDAC6
- GMNN
- GLP1R
- GBA1
- CYP3A4
- ATXN2
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- ANDR
- RARA
- PDK4
- PDK3
- PDK2
- PDK1
- NR1I2
- KCNH2
- GNRHR
- GLI3
- ESRRA
- ESR2
- DRD2
- CP3A4
- CP2D6
- CP2CJ
- CP1A2
- CP19A
- CASP7
- CASP3
- VDR
Cross-references
Synonyms
- RefChem:420300
- gw 405833
- GW405833
- L-768242
- J2.981.899A
- GW-405,833
- UNII-85K154W99L
- FSFZRNZSZYDVLI-UHFFFAOYSA-N
- HMS3268P12
- MFCD08061200
- A1IV2
- SCHEMBL430254
- C23H24Cl2N2O3
- L-768,242
- orb1299576
- SCHEMBL29426317
- SCHEMBL29448220
- SCHEMBL29835924
- CHEBI:92184
- GTPL11149
- HMS3413I10
- HMS3677I10
- FHA00283
- BDBM50234418
- EX-A11142
- MFCD09832650
- AKOS015896972
- SDCCGSBI-0633750.P001
- NCGC00092382-01
- NCGC00092382-02
- AS-37651
- DB-016268
- HY-110036
- CS-0032859
- G0600
- T7705
- G880000
- L768242
- BRD-K10705233-001-01-4
Look up GW-405833 in the interactive SynDRA portal →